ArticleHemaSphere2022

Limitations of Monitoring Disease Progression Using Circulating Tumor DNA in Lymphoma: An Example From Primary Cutaneous DLBCL Leg-type.

Christopher S Trethewey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.